BDBM362851 (R)-(3,4-difluorophenyl)(8- methyl-3-(2- (trifluoromethyl)thiazol-4-yl)- 5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)methanone::US9840508, Compound 13

SMILES C[C@H]1N(CCn2c1nnc2-c1csc(n1)C(F)(F)F)C(=O)c1ccc(F)c(F)c1

InChI Key InChIKey=KTZUFWFRVQNNLJ-UHFFFAOYSA-N

Data  4 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 362851   

TargetNeuromedin-K receptor(Human)
Oged

US Patent
LigandPNGBDBM362851(US9840508, Compound 13 | (R)-(3,4-difluorophenyl)(...)
Affinity DataIC50: 26nMAssay Description:The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an in vitro ra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2019
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Oged

US Patent
LigandPNGBDBM362851(US9840508, Compound 13 | (R)-(3,4-difluorophenyl)(...)
Affinity DataKi:  20nMAssay Description:The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an in vitro ra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2019
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Oged

US Patent
LigandPNGBDBM362851(US9840508, Compound 13 | (R)-(3,4-difluorophenyl)(...)
Affinity DataKi:  20nMAssay Description:The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an in vitro ra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2019
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Oged

US Patent
LigandPNGBDBM362851(US9840508, Compound 13 | (R)-(3,4-difluorophenyl)(...)
Affinity DataKi:  7.00E+3nMAssay Description:The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2019
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Oged

US Patent
LigandPNGBDBM362851(US9840508, Compound 13 | (R)-(3,4-difluorophenyl)(...)
Affinity DataKi:  2.10E+4nMAssay Description:The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2019
Entry Details
Go to US Patent